Literature DB >> 26517929

TRIB2 and the ubiquitin proteasome system in cancer.

Mara Salomè1, Joana Campos1, Karen Keeshan2.   

Abstract

Tribbles family of pseudokinase proteins are known to mediate the degradation of target proteins in Drosophila and mammalian systems. The main protein proteolysis pathway in eukaryotic cells is the ubiquitin proteasome system (UPS). The tribbles homolog 2 (TRIB2) mammalian family member has been well characterized for its role in murine and human leukaemia, lung and liver cancer. One of the most characterized substrates for TRIB2-mediated degradation is the myeloid transcription factor CCAAT enhancer binding protein α (C/EBPα). However, across a number of cancers, the molecular interactions that take place between TRIB2 and factors involved in the UPS are varied and have differential downstream effects. This review summarizes our current knowledge of these interactions and how this information is important for our understanding of TRIB2 in cancer.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  TRIB2; cancer; leukaemia; ubiquitin proteasome

Mesh:

Substances:

Year:  2015        PMID: 26517929     DOI: 10.1042/BST20150103

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  11 in total

Review 1.  Fine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis.

Authors:  Willy Roque; Ross Summer; Freddy Romero
Journal:  Connect Tissue Res       Date:  2018-10-22       Impact factor: 3.417

2.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

Review 3.  Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.

Authors:  Patrick A Eyers; Karen Keeshan; Natarajan Kannan
Journal:  Trends Cell Biol       Date:  2016-11-28       Impact factor: 20.808

4.  Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2.

Authors:  Caitriona O'Connor; Krishna Yalla; Mara Salomé; Hothri Ananyambica Moka; Eduardo Gómez Castañeda; Patrick A Eyers; Karen Keeshan
Journal:  Oncotarget       Date:  2018-02-19

5.  Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.

Authors:  Bo Chen; Tianshun Gao; Weiwei Yuan; Weihong Zhao; Tza-Huei Wang; Jianqing Wu
Journal:  J Cancer       Date:  2019-10-06       Impact factor: 4.207

6.  CHIP-mediated ubiquitination of Galectin-1 predicts colorectal cancer prognosis.

Authors:  Weimin Wang; Zhen Zhou; Liangliang Xiang; Mengying Lv; Tengyang Ni; Jianliang Deng; Haibo Wang; Sunagawa Masatara; Yan Zhou; Yanqing Liu
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

7.  TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress.

Authors:  Susu Guo; Yuxin Chen; Yueyue Yang; Xiao Zhang; Lifang Ma; Xiangfei Xue; Yongxia Qiao; Jiayi Wang
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

8.  Human TRIB2 Oscillates during the Cell Cycle and Promotes Ubiquitination and Degradation of CDC25C.

Authors:  Kai Ling Liang; Roberto Paredes; Ruaidhri Carmody; Patrick A Eyers; Stefan Meyer; Tommie V McCarthy; Karen Keeshan
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

Review 9.  Tribbles homolog 2 (Trib2), a pseudo serine/threonine kinase in tumorigenesis and stem cell fate decisions.

Authors:  Yu Fang; Angelina Olegovna Zekiy; Farhoodeh Ghaedrahmati; Anton Timoshin; Maryam Farzaneh; Amir Anbiyaiee; Seyed Esmaeil Khoshnam
Journal:  Cell Commun Signal       Date:  2021-04-01       Impact factor: 5.712

10.  TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis.

Authors:  Dae Kyoung Kim; Yu Na Kim; Ye Eun Kim; Seo Yul Lee; Min Joo Shin; Eun Kyoung Do; Kyung-Un Choi; Seung-Chul Kim; Ki-Hyung Kim; Dong-Soo Suh; Parkyong Song; Jae Ho Kim
Journal:  Mol Cells       Date:  2021-07-31       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.